Mofezolac

Mofezolac
Systematic (IUPAC) name

[3,4-bis(4-methoxyphenyl)isoxazol-5-yl]acetic acid
Clinical data
AHFS/Drugs.com	International Drug Names
Legal status	℞ (Prescription only)
Routes of administration	Oral
Identifiers
CAS Registry Number	78967-07-4^Y
ATC code	None
PubChem	CID 4237
ChemSpider	4089
UNII	RVJ0BV3H3Y^Y
KEGG	D01718^Y
Chemical data
Formula	C₁₉H₁₇N O₅
Molecular mass	339.34 g/mol
SMILES COC1=CC=C(C=C1)C2=C(ON=C2C3=CC=C(C=C3)OC)CC(=O)O
InChI InChI=1S/C19H17NO5/c1-23-14-7-3-12(4-8-14)18-16(11-17(21)22)25-20-19(18)13-5-9-15(24-2)10-6-13/h3-10H,11H2,1-2H3,(H,21,22) Key:DJEIHHYCDCTAAH-UHFFFAOYSA-N
Y (what is this?) (verify)

Mofezolac (INN) is a non-steroidal anti-inflammatory drug.

Non-steroidal anti-inflammatory drugs (NSAIDs) (primarily M01A and M02A, also N02BA)

Acetic acid derivatives
and related substances

Propionic acid derivatives
(profens)

N-Arylanthranilic acids
(fenamates)

Other

Items listed in bold indicate initially developed compounds of specific groups. ^#WHO-EM ^†Withdrawn drugs. ^‡Veterinary use medications.

Index of muscle

Description	Anatomy head neck arms chest and back diaphragm abdomen genital area legs Muscle tissue Physiology connective tissue

Disease	Myopathy Soft tissue Connective tissue Congenital abdomen muscular dystrophy Neoplasms and cancer Injury Symptoms and signs eponymous

Treatment	Procedures Drugs anti-inflammatory muscle relaxants